Lauren S Prescott1, Andrea S Dickens2, Sandra L Guerra3, Jila M Tanha4, Desiree G Phillips5, Katherine T Patel2, Katie M Umberson6, Miguel A Lozano7, Kathryn B Lowe8, Alaina J Brown3, Jolyn S Taylor3, Pamela T Soliman3, Elizabeth A Garcia3, Charles F Levenback3, Diane C Bodurka3. 1. Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. Electronic address: LSPrescott@mdanderson.org. 2. Pharmacy, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 3. Departments of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 4. The Learning Center, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 5. Patient Education, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 6. Clinical Operations, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 7. Performance Improvement, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. 8. Department of Supportive Medicine, Memorial Hermann Healthcare System, Houston, TX, United States.
Abstract
OBJECTIVE: Shared medical appointments offer a novel approach to improve efficiency and quality of care consistent with the goals of the Institute of Medicine. Our objective was to develop and implement a shared medical appointment for gynecologic cancer patients initiating chemotherapy. METHODS: We first assessed the level of interest in shared medical appointments among our patients and providers through qualitative interviews. Both patients and providers identified pre-chemotherapy as an optimal area to pilot shared medical appointments. We subsequently created a multidisciplinary team comprised of physicians, advanced practice providers, nurses, pharmacists, administrators, health education specialists and members of the Quality Improvement Department to establish a Shared Medical Appointment and Readiness Teaching (SMART) program for all gynecologic oncology patients initiating chemotherapy with platinum- and/or taxane-based regimens. We developed a standardized chemotherapy education presentation and provided patients with a tool kit that consisted of chemotherapy drug education, a guide to managing side effects, advance directives, and center contact information. RESULTS: From May 9, 2014 to June 26, 2015, 144 patients participated in 51 SMART visits. The majority of patients had ovarian cancer and were treated with carboplatin/paclitaxel. Surveyed patients reported being highly satisfied with the group visit and would recommend shared medical appointments to other patients. CONCLUSIONS: This model of care provides patient education within a framework of social support that empowers patients. Shared medical appointments for oncology patients initiating chemotherapy are both feasible and well accepted.
OBJECTIVE: Shared medical appointments offer a novel approach to improve efficiency and quality of care consistent with the goals of the Institute of Medicine. Our objective was to develop and implement a shared medical appointment for gynecologic cancerpatients initiating chemotherapy. METHODS: We first assessed the level of interest in shared medical appointments among our patients and providers through qualitative interviews. Both patients and providers identified pre-chemotherapy as an optimal area to pilot shared medical appointments. We subsequently created a multidisciplinary team comprised of physicians, advanced practice providers, nurses, pharmacists, administrators, health education specialists and members of the Quality Improvement Department to establish a Shared Medical Appointment and Readiness Teaching (SMART) program for all gynecologic oncology patients initiating chemotherapy with platinum- and/or taxane-based regimens. We developed a standardized chemotherapy education presentation and provided patients with a tool kit that consisted of chemotherapy drug education, a guide to managing side effects, advance directives, and center contact information. RESULTS: From May 9, 2014 to June 26, 2015, 144 patients participated in 51 SMART visits. The majority of patients had ovarian cancer and were treated with carboplatin/paclitaxel. Surveyed patients reported being highly satisfied with the group visit and would recommend shared medical appointments to other patients. CONCLUSIONS: This model of care provides patient education within a framework of social support that empowers patients. Shared medical appointments for oncology patients initiating chemotherapy are both feasible and well accepted.
Authors: Alexander B Guirguis; Joan Lugovich; Jennifer Jay; Kathryn A Sanders; Seth T Cioffi; Sean M Jeffery; Jeffrey D Kravetz Journal: Am J Med Date: 2013-09-25 Impact factor: 4.965
Authors: Femke Marie Seesing; Gea Drost; Johannes Groenewoud; Gert Jan van der Wilt; Baziel G M van Engelen Journal: Neurology Date: 2014-06-18 Impact factor: 9.910
Authors: Ariana Thompson-Lastad; Chloe E Atreya; Maria T Chao; Christine Pollak; Anand Dhruva; Trilce Santana; Donald I Abrams Journal: J Altern Complement Med Date: 2019-07 Impact factor: 2.579